Selumetinib, a drug that’s approved to treat certain types of neurological tumors, may be an effective treatment for skin cancers in people with recessive dystrophic epidermolysis bullosa (RDEB), according to a new study. Researchers found that selumetinib treatment killed cancer cells in dish-based tests, while experiments in mouse models…